Construction of GPC3-modified Lipopolymer SiRNA Delivery System
- 1 May 2024
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 30 (19) , 1507-1518
Abstract
Background: Gene therapy has been widely concerned because of its unique therapeutic mechanism. However, due to the lack of safe and effective carries, it has not been widely used in clinical practice. Glypican 3 (GPC3) is a highly specific proteoglycan for hepatocellular carcinoma and is a potential diagnostic and therapeutic target for hepatocellular carcinoma. Herein, to monitor the effect of gene therapy and enhance the transfection efficiency of gene carriers, GPC3-modified lipid polyethyleneimine-modified superparamagnetic nanoparticle (GLPS), a type of visualized carrier for siRNA (small-interfering RNA) targeting the liver, was prepared. Methods: We performed in vitro gene silencing, cytotoxicity, and agarose gel electrophoresis to identify the optimal GLPS formulation. In vitro MRI and Prussian blue staining verified the liver-targeting function of GLPS. We also analyzed the biocompatibility of GLPS by co-culturing with rabbit red blood cells. Morphological changes were evaluated using HE staining. Results: The GLPS optimal formulation consisted of LPS and siRNA at a mass ratio of 25:1 and LPS and DSPE-PEG-GPC3 at a molar ratio of 2:3. GLPS exhibited evident liver-targeting function. In vitro, we did not observe morphological changes in red blood cells or hemolysis after co-culture. In vivo, routine blood analysis revealed no abnormalities after GLPS injection. Moreover, the tissue morphology of the kidney, spleen, and liver was normal without injury or inflammation. Conclusion: GLPS could potentially serve as an effective carrier for liver-targeted MRI monitoring and siRNA delivery.Keywords
Funding Information
- National Natural Science Foundation of China (82160329, 81860304)
- Natural Science Research Foundation of Jilin Province for Sciences and Technology (20200201511JC)
This publication has 39 references indexed in Scilit:
- siRNA and targeted delivery systems in breast cancer therapyClinical and Translational Oncology, 2022
- GPC3-targeted immunoPET imaging of hepatocellular carcinomasEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Surface functionalized dendrimers as controlled-release delivery nanosystems for tumor targetingEuropean Journal of Pharmaceutical Sciences, 2018
- Fluorescent Photo-conversion: A Second Chance to Label Unique CellsCellular and Molecular Bioengineering, 2014
- Folate–PEG–superparamagnetic iron oxide nanoparticles for lung cancer imagingActa Biomaterialia, 2012
- Silencing glypican-3 expression induces apoptosis in human hepatocellular carcinoma cellsBiochemical and Biophysical Research Communications, 2012
- The Oncogenic Effect of Sulfatase 2 in Human Hepatocellular Carcinoma Is Mediated in Part by Glypican 3–Dependent Wnt ActivationHepatology, 2010
- Serum-resistant lipopolyplexes for gene delivery to liver tumour cellsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2007
- In vitro hemolysis: Guidance for the pharmaceutical scientistJournal of Pharmaceutical Sciences, 2006
- Polyethylenimine-based non-viral gene delivery systemsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2005